<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(3)</volume><submitter>Martinez C</submitter><funding>Bayer AG</funding><funding>Bayer</funding><pubmed_abstract>Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of unresolved organised pulmonary emboli/thrombi obstructing the major pulmonary arteries. The aim of this study was to estimate the incidence and risk factors of CTEPH in a cohort with first venous thromboembolism (VTE). This was a population-based cohort study of patients with first VTE and no active cancer in England between 2001 and 2012. CTEPH was assessed using a rigorous case-ascertainment algorithm. Risk factors for CTEPH were studied using a nested case-control approach by matching CTEPH cases to VTE patients without CTEPH. Adjusted odds ratios (OR) of comorbidities were estimated from conditional logistic regression. During 81,413 person-years of follow-up among 23,329 patients with first VTE (mean follow-up </pubmed_abstract><journal>Pulmonary circulation</journal><pagination>2045894018791358</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6066824</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England.</pubmed_title><pmcid>PMC6066824</pmcid><pubmed_authors>Wallenhorst C</pubmed_authors><pubmed_authors>Cohen AT</pubmed_authors><pubmed_authors>Peacock AJ</pubmed_authors><pubmed_authors>Martinez C</pubmed_authors><pubmed_authors>Teal S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England.</name><description>Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of unresolved organised pulmonary emboli/thrombi obstructing the major pulmonary arteries. The aim of this study was to estimate the incidence and risk factors of CTEPH in a cohort with first venous thromboembolism (VTE). This was a population-based cohort study of patients with first VTE and no active cancer in England between 2001 and 2012. CTEPH was assessed using a rigorous case-ascertainment algorithm. Risk factors for CTEPH were studied using a nested case-control approach by matching CTEPH cases to VTE patients without CTEPH. Adjusted odds ratios (OR) of comorbidities were estimated from conditional logistic regression. During 81,413 person-years of follow-up among 23,329 patients with first VTE (mean follow-up </description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jul-Sep</publication><modification>2025-04-04T20:29:43.258Z</modification><creation>2019-03-26T23:49:55Z</creation></dates><accession>S-EPMC6066824</accession><cross_references><pubmed>29985100</pubmed><doi>10.1177/2045894018791358</doi></cross_references></HashMap>